Teresa Bowman

Dr. Teresa Bowman


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Developmental Cell
Verified
Journal Article
Closed access
JWJoshua T. Weinreb
Joshua T. Weinreb
NGNoura Ghazale
Noura Ghazale
KPKith Pradhan
Kith Pradhan
VGVarun Gupta
Varun Gupta
KPKathryn S. Potts
Kathryn S. Potts
TBTeresa Bowman
Teresa Bowman

20 March 2019 in WIREs RNA
Verified
Journal Article
Closed access
PDF file
SNSara Nik
Sara Nik
TBTeresa Bowman
Teresa Bowman

1 September 2021 in Cell Reports
Verified
Journal Article
Open access
BUBianca A. Ulloa
Bianca A. Ulloa
SHSamima S. Habbsa
Samima S. Habbsa
KPKathryn S. Potts
Kathryn S. Potts
ALAlana Lewis
Alana Lewis
MMMia McKinstry
Mia McKinstry
TBTeresa Bowman
Teresa Bowman
Hematopoietic stem cells (HSCs) are rare cells that arise in the embryo and sustain adult hematopoiesis. Although the functional potential of nascent HSCs is detectable by transplantation, their native contribution during development is unknown, in part due to the overlapping genesis and marker gene expression with other embryonic blood progenitors. Using single-cell transcriptomics, we define gene signatures that distinguish nascent HSCs from embryonic blood progenitors. Applying a lineage-tracing approach to selectively track HSC output in situ, we find significantly delayed lymphomyeloid contribution. An inducible HSC injury model demonstrates a negligible impact on larval lymphomyelopoiesis following HSC depletion. HSCs are not merely dormant at this developmental stage, as they showed robust regeneration after injury. Combined, our findings illuminate that nascent HSCs self-renew but display differentiation latency, while HSC-independent embryonic progenitors sustain developmental hematopoiesis. Understanding these differences could improve de novo generation and expansion of functional HSCs.

1 March 2021 in Haematologica
Verified
Journal Article
Open access
PDF file
JWJoshua T. Weinreb
Joshua T. Weinreb
VGVarun Gupta
Varun Gupta
ESElianna Sharvit
Elianna Sharvit
RWRachel Weil
Rachel Weil
TBTeresa Bowman
Teresa Bowman
DEAD-box Helicase 41 (DDX41) is a recently identified factor mutated in hematologic malignancies whose function in hematopoiesis is unknown. Using an in vivo model of Ddx41 deficiency, we unveiled a critical role for this helicase in regulating erythropoiesis. We demonstrated that loss of ddx41 leads to anemia caused by diminished proliferation and defective differentiation of erythroid progenitors. Mis-expression and alternative splicing of cell cycle genes is rampant in ddx41 mutant erythroid progenitors. We delineated that the DNA damage response is activated in mutant cells resulting in an Ataxiatelangiectasia mutated (ATM) and Ataxia-telangiectasia and Rad3-related (ATR)-triggered cell cycle arrest. Inhibition of these kinases partially suppressed ddx41 mutant anemia. These findings establish a critical function for Ddx41 in promoting healthy erythropoiesis via protection from genomic stress and delineate a mechanistic framework to explore a role for ATM and ATR signaling in DDX41-mutant hematopoietic pathologies.

1 February 2018 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
SSShelly Sorrells
Shelly Sorrells
SNSara Nik
Sara Nik
MCMattie Casey
Mattie Casey
RCRosannah C. Cameron
Rosannah C. Cameron
HTHarold Truong
Harold Truong
TBTeresa Bowman
Teresa Bowman
RNA splicing factors are essential for the viability of all eukaryotic cells; however, in metazoans some cell types are exquisitely sensitive to disruption of splicing factors. Neuronal cells represent one such cell type, and defects in RNA splicing factors can lead to neurodegenerative diseases. The basis for this tissue selectivity is not well understood owing to difficulties in analyzing the consequences of splicing factor defects in whole-animal systems. Here, we use zebrafish mutants to show that loss of spliceosomal components, including splicing factor 3b, subunit 1 (sf3b1), causes increased DNA double-strand breaks and apoptosis in embryonic neurons. Moreover, these mutants show a concomitant accumulation of R-loops, which are non-canonical nucleic acid structures that promote genomic instability. Dampening R-loop formation by conditional induction of ribonuclease H1 in sf3b1 mutants reduced neuronal DNA damage and apoptosis. These findings show that splicing factor dysfunction leads to R-loop accumulation and DNA damage that sensitizes embryonic neurons to apoptosis. Our results suggest that diseases associated with splicing factor mutations could be susceptible to treatments that modulate R-loop levels.

1 September 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MCMartina Cusan
Martina Cusan
HSHaifeng Shen
Haifeng Shen
BZBo Zhang
Bo Zhang
ALAijun Liao
Aijun Liao
LYLu Yang
Lu Yang
LWLili Wang
Lili Wang
RNA splicing factor SF3B1 is recurrently mutated in various cancers, particularly in hematologic malignancies. We previously reported that coexpression of Sf3b1 mutation and Atm deletion in B cells, but not either lesion alone, leads to the onset of chronic lymphocytic leukemia (CLL) with CLL cells harboring chromosome amplification. However, the exact role of Sf3b1 mutation and Atm deletion in chromosomal instability (CIN) remains unclear. Here, we demonstrated that SF3B1 mutation promotes centromeric R-loop (cen-R-loop) accumulation, leading to increased chromosome oscillation, impaired chromosome segregation, altered spindle architecture, and aneuploidy, which could be alleviated by removal of cen-R-loop and exaggerated by deletion of ATM. Aberrant splicing of key genes involved in R-loop processing underlay augmentation of cen-R-loop, as overexpression of the normal isoform, but not the altered form, mitigated mitotic stress in SF3B1-mutant cells. Our study identifies a critical role of splice variants in linking RNA splicing dysregulation and CIN and highlights cen-R-loop augmentation as a key mechanism for leukemogenesis.